HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ignace Vergote Selected Research

Hormones (Hormone)

6/2017Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer.
1/2016Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
3/2015Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
5/2009Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
4/2009Management of recurrent endometrioid endometrial carcinoma: an overview.
5/2008Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study.
12/2006Transition of endometrial stromal sarcoma into high-grade sarcoma.
6/2005A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer.
6/2004Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
5/2004The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ignace Vergote Research Topics

Disease

199Ovarian Neoplasms (Ovarian Cancer)
05/2024 - 01/2003
179Neoplasms (Cancer)
05/2024 - 01/2003
48Carcinoma (Carcinomatosis)
04/2024 - 01/2002
41Ovarian Epithelial Carcinoma
05/2024 - 02/2003
38Endometrial Neoplasms (Endometrial Cancer)
04/2024 - 03/2002
30Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2024 - 01/2002
29Breast Neoplasms (Breast Cancer)
01/2021 - 05/2003
19Disease Progression
12/2023 - 07/2003
15Ascites
03/2022 - 12/2005
12Neutropenia
01/2023 - 05/2003
10Nausea
03/2024 - 05/2003
10Neoplasm Metastasis (Metastasis)
03/2023 - 01/2002
8Vomiting
03/2024 - 04/2012
8Fatigue
11/2022 - 02/2012
8Residual Neoplasm
01/2022 - 02/2003
6Hypertension (High Blood Pressure)
01/2023 - 05/2014
6Thrombocytopenia (Thrombopenia)
01/2023 - 10/2014
6Anemia
11/2022 - 04/2012
5Vulvar Neoplasms (Vulvar Cancer)
11/2021 - 09/2008
5Fallopian Tube Neoplasms
01/2021 - 04/2016
5Carcinogenesis
03/2016 - 12/2008
4Peritoneal Neoplasms
03/2023 - 01/2014
4Carcinosarcoma
01/2023 - 11/2003
4Proteinuria
01/2022 - 05/2014
4Diarrhea
01/2019 - 10/2014
4Endometrioid Carcinoma
10/2015 - 12/2008
3Genomic Instability
06/2023 - 01/2023
3Pain (Aches)
10/2022 - 12/2005
3Chromosomal Instability (Chromosome Stability)
04/2022 - 01/2016
3Adenocarcinoma
01/2021 - 03/2007

Drug/Important Bio-Agent (IBA)

101PlatinumIBA
05/2024 - 01/2003
41Paclitaxel (Taxol)FDA LinkGeneric
03/2024 - 03/2003
40Carboplatin (JM8)FDA LinkGeneric
04/2024 - 10/2006
35Biomarkers (Surrogate Marker)IBA
04/2024 - 02/2003
25olaparibIBA
04/2024 - 02/2012
24Bevacizumab (Avastin)FDA Link
04/2024 - 05/2014
18Proteins (Proteins, Gene)FDA Link
04/2024 - 04/2009
14Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2024 - 02/2012
14liposomal doxorubicin (Doxil)FDA Link
01/2023 - 07/2010
13Progesterone Receptors (Progesterone Receptor)IBA
01/2019 - 02/2003
13Estrogen ReceptorsIBA
01/2019 - 02/2003
13Hormones (Hormone)IBA
06/2017 - 02/2003
12DNA (Deoxyribonucleic Acid)IBA
05/2024 - 05/2014
12Messenger RNA (mRNA)IBA
05/2024 - 12/2006
10Immunoconjugates (Immunoconjugate)IBA
03/2024 - 07/2018
9Estrogens (Estrogen)FDA Link
01/2018 - 06/2004
8taxaneIBA
04/2024 - 07/2010
7ErbB Receptors (EGF Receptor)IBA
05/2024 - 06/2007
7Cisplatin (Platino)FDA LinkGeneric
03/2024 - 01/2005
71-dodecylpyridoxal (PLD)IBA
01/2022 - 07/2010
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019 - 02/2012
7Aromatase InhibitorsIBA
02/2014 - 05/2004
6Topotecan (Hycamtin)FDA LinkGeneric
03/2024 - 05/2003
6mirvetuximab soravtansineIBA
03/2024 - 01/2018
6ParaffinIBA
06/2023 - 12/2008
6VaccinesIBA
01/2022 - 09/2010
6RNA (Ribonucleic Acid)IBA
01/2021 - 02/2015
6TamoxifenFDA LinkGeneric
01/2018 - 11/2003
5niraparibIBA
03/2024 - 12/2016
5Immune Checkpoint InhibitorsIBA
03/2024 - 01/2021
5pembrolizumabIBA
11/2023 - 01/2022
5tisotumab vedotinIBA
08/2023 - 01/2020
5GemcitabineFDA Link
06/2021 - 03/2003
5trebananibIBA
01/2019 - 07/2014
5Folic Acid (Vitamin M)FDA LinkGeneric
07/2018 - 05/2014
5Fulvestrant (Faslodex)FDA Link
05/2008 - 07/2003
4AntigensIBA
12/2023 - 09/2011
4Thromboplastin (Tissue Factor)IBA
08/2023 - 01/2020
4Tyrosine Kinase InhibitorsIBA
01/2023 - 06/2007
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 - 06/2016
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020 - 05/2014
4Interleukin-10 (Interleukin 10)IBA
11/2019 - 04/2014
4MicroRNAs (MicroRNA)IBA
01/2016 - 06/2011
4thiaclopridIBA
02/2015 - 08/2011
4Transcription Factors (Transcription Factor)IBA
01/2015 - 12/2008
4Anastrozole (Arimidex)FDA LinkGeneric
02/2011 - 07/2003
3Circulating Tumor DNAIBA
05/2024 - 02/2015
3selinexorIBA
04/2024 - 12/2023
3Folate Receptor 1IBA
03/2024 - 10/2018
3Tumor Biomarkers (Tumor Markers)IBA
05/2023 - 06/2007
3Taxoids (Taxanes)IBA
01/2023 - 08/2011
3lenvatinibIBA
01/2023 - 01/2020
3CyclinsIBA
01/2023 - 01/2014
3CytokinesIBA
11/2021 - 01/2018
3Adenosine Diphosphate (ADP)IBA
12/2019 - 04/2012

Therapy/Procedure

106Drug Therapy (Chemotherapy)
04/2024 - 01/2003
84Therapeutics
05/2024 - 05/2003
27Neoadjuvant Therapy
11/2023 - 11/2005
18Lymph Node Excision (Lymph Node Dissection)
11/2021 - 01/2002
17Immunotherapy
04/2024 - 09/2010
13Adjuvant Chemotherapy
11/2021 - 01/2003
11Cytoreduction Surgical Procedures
12/2021 - 02/2011
10Radiotherapy
11/2021 - 01/2002
10Hysterectomy
01/2021 - 03/2007
6Aftercare (After-Treatment)
03/2024 - 03/2003
6Hyperthermic Intraperitoneal Chemotherapy
12/2023 - 01/2018
5Palliative Care (Palliative Therapy)
03/2023 - 03/2003
4Investigational Therapies (Experimental Therapy)
01/2023 - 01/2017
4Salpingo-oophorectomy
01/2020 - 01/2008
3Minimally Invasive Surgical Procedures
11/2021 - 01/2016